Results 161 to 170 of about 87,208 (292)

Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502 [PDF]

open access: green
Shun Yamamoto   +18 more
openalex   +1 more source

Supplementary Data from Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability–High Locally Advanced Rectal Cancer

open access: gold, 2023
Hideaki Bando   +24 more
openalex   +1 more source

Development and Validation of a Urinary Exosomal miRNA Diagnostic Panel for Early Detection of Esophageal Cancer

open access: yesCancer Science, EarlyView.
Using a machine learning–based approach in a multi‐institutional prospective cohort, we identified a robust miRNA signature that demonstrated high diagnostic accuracy for esophageal squamous cell carcinoma. Our 57‐miRNA panel achieved an AUC of 0.90 in the proof‐of‐concept cohort and 0.85 in an independent validation cohort, with a sensitivity of 84 ...
Tatsuro Murano   +14 more
wiley   +1 more source

Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer [PDF]

open access: bronze, 2018
Olarn Roengvoraphoj   +9 more
openalex   +1 more source

FB23‐2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF/ERCC1 Complex

open access: yesCancer Science, EarlyView.
FB23‐2 potentiates cisplatin's antitumor efficacy in head and neck squamous cell carcinoma by disrupting XPF/ERCC1 complex assembly and nuclear translocation, thereby suppressing DNA damage repair machinery and amplifying platinum‐induced tumor cell death.
Yaoqi Jiang   +7 more
wiley   +1 more source

Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma

open access: yesInternational Journal of Nanomedicine
Chuanfeng Zhang, Zhen Guo, Zhao Jing Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, 310013, People’s Republic of ChinaCorrespondence: Zhao Jing, Department of Oncology, Zhejiang Hospital, No.
Zhang C, Guo Z, Jing Z
doaj  

IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα‐Independent Apoptosis

open access: yesCancer Science, EarlyView.
Upon chemotherapy, a subset of cancer cells enters a senescent state, referred to as TIS. When IAP antagonists are administered, TIS cells are selectively eliminated through TNFα‐independent apoptosis. TNFα secreted by TIS cancer cells may also act in a paracrine manner to enhance extrinsic apoptosis in neighboring non‐senescent cancer cells.
Hiroaki Ochiiwa   +7 more
wiley   +1 more source

Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy. [PDF]

open access: yesNat Commun
Zhang L   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy